J147

· Abrexa Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for J147, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of J147 in Acute Ischemic Stroke [Phase 2]